Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
Wang X, Hu B, Shen H, Zhou H, Xue X, Chen Y, Chen S, Han Y, Yuan B, Zhao H, Zhi Q, Kuang Y.
Wang X, et al.
Biomed Pharmacother. 2015 Oct;75:218-25. doi: 10.1016/j.biopha.2015.07.038. Epub 2015 Aug 10.
Biomed Pharmacother. 2015.
PMID: 26271144
Review.